Form 10-Q Syros Pharmaceuticals, For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. REGN
2. CRWD
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Form 10-Q Syros Pharmaceuticals, For: Sep 30

Syros Pharmaceuticals (SYRS) Misses Q3 EPS by 11c

November 14, 2016 8:09 AM EST

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q3 EPS of ($0.65), $0.11 worse than the analyst estimate of ($0.54).

Cash and cash equivalents as of September 30, 2016 were $93.5 million, compared with $35.9 million on December 31, 2015. The increase in cash includes the net proceeds from the Companys IPO that... More